Home/Filings/4/0001638599-17-000105
4//SEC Filing

Fortress Biotech, Inc. 4

Accession 0001638599-17-000105

$FBIOCIK 0001429260operating

Filed

Jan 23, 7:00 PM ET

Accepted

Jan 24, 6:54 PM ET

Size

14.5 KB

Accession

0001638599-17-000105

Insider Transaction Report

Form 4
Period: 2017-01-01
Transactions
  • Award

    Deferred Restricted Stock Units

    2017-01-01+16,66633,332 total
    Exercise: $0.00Common Stock (16,666 underlying)
Holdings
  • Options to purchase Common Stock

    Exercise: $1.37Exp: 2020-10-05Common Stock (25,000 underlying)
    25,000
  • Options to purchase Common Stock

    Exercise: $6.25Exp: 2022-02-10Common Stock (15,000 underlying)
    15,000
  • Options to purchase Common Stock

    Exercise: $2.10Exp: 2023-12-19Common Stock (30,000 underlying)
    30,000
  • Common Stock, par value $0.001

    50,000
Footnotes (7)
  • [F1]The Reporting Person was granted restricted stock units ("RSUs") for service as a director in 2016, vesting one-third annually beginning on January 1, 2017. The Reporting Person deferred receipt of all the common stock upon the vesting of the RSUs under the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Each deferred RSU that has vested will be settled in one share of the Issuer's common stock at the time and in the manner set forth in the Plan.
  • [F2]Upon the vesting of RSUs, the Reporting Person deferred the receipt of 16,666 shares of common stock and received instead 16,666 shares of deferred RSUs.
  • [F3]The Reporting Person was granted RSUs for service on the Strategic Transaction Committee in 2016, vesting one-third annually beginning on January 1, 2017. The Reporting Person deferred receipt of all the common stock upon the vesting of the RSUs under the Plan. Each deferred RSU that has vested will be settled in one share of the Issuer's common stock at the time and in the manner set forth in the Plan.
  • [F4]One-third of the shares vested on each of October 5, 2011, 2012 and 2013.
  • [F5]One-third of the shares vested on each of February 10, 2013, 2014 and 2015.
  • [F6]One-third of the shares vested on each of February 7, 2014, 2015 and 2016.
  • [F7]One-third of the shares vested on each of December 19, 2014, 2015 and 2016.

Issuer

Fortress Biotech, Inc.

CIK 0001429260

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001429260

Filing Metadata

Form type
4
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 6:54 PM ET
Size
14.5 KB